Literature DB >> 32288559

Management of exacerbations of COPD.

Terence Seemungal1, Jadwiga A Wedzicha2.   

Abstract

Exacerbations of chronic obstructive pulmonary disease (COPD) are an important cause of morbidity and mortality in the condition, and their incidence increases with its severity. Some patients suffer frequent exacerbations leading to hospital admission, with considerable impact on their quality of life and activities of daily living. COPD exacerbations are associated with considerable physiological deterioration and increased airway inflammatory changes caused by factors such as viruses, bacteria and, possibly, common pollutants. Current evidence suggests that appropriate management and prevention of exacerbations may modify the long-term course of COPD.
Copyright © 2003 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COPD; exacerbations; management

Year:  2006        PMID: 32288559      PMCID: PMC7129387          DOI: 10.1383/medc.31.12.82.27175

Source DB:  PubMed          Journal:  Medicine (Abingdon)        ISSN: 1357-3039


  5 in total

1.  Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.

Authors:  L Davies; R M Angus; P M Calverley
Journal:  Lancet       Date:  1999-08-07       Impact factor: 79.321

2.  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.

Authors: 
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

3.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

Authors:  T A Seemungal; G C Donaldson; A Bhowmik; D J Jeffries; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

Review 4.  Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease.

Authors:  M Greenstone
Journal:  Cochrane Database Syst Rev       Date:  2000

5.  Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.

Authors:  D E Niewoehner; M L Erbland; R H Deupree; D Collins; N J Gross; R W Light; P Anderson; N A Morgan
Journal:  N Engl J Med       Date:  1999-06-24       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.